No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
632 |
4. Check minimum number of eventsNone |
632 |
5. Include endpointsNone |
632 |
6. Filter based on genotype QC (FinnGen only) |
632 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA, G6_ALZHEIMER, G6_AD_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F01
- Name in latin
- Dementia e multis infarctibus
Similar endpoints
↥List of similar endpoints to
Vascular dementia (multiple infarctions)
based on the number of shared cases.
Similar with more cases:
- Vascular dementia
- Dementia
- Dementia, including avohilmo
- Organic, including symptomatic, mental disorders
- Psychiatric diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 17740 | 8997 | 8189 |
| Only index persons | 5236 | 2717 | 2519 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.25 | 0.26 | 0.23 |
| Only index persons | 0.10 | 0.10 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 79.25 | 80.73 | 77.74 |
| Only index persons | 80.26 | 82.38 | 77.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 632 | 186 | 446 |
| Unadjusted period prevalence (%) | 0.16 | 0.06 | 0.20 |
| Median age at first event (years) | 76.77 | 78.54 | 76.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 584
- Matched controls
- 5840
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
+∞
262.8
232
*
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
2576.8
191.5
175
*
F01.1
ICD-10 Finland
Multi-infarct dementia
2362.9
180.9
166
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
222.4
137.1
137
8
F03
ICD-10 Finland
Unspecified dementia
81.9
133.7
148
24
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
7.9
84.4
225
428
N06DX01
ATC
memantine; oral
104.0
75.1
81
9
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
69.1
65
*
N06DA02
ATC
donepezil; oral
121.3
61.2
65
6
N05AX08
ATC
risperidone; systemic
10.5
55.8
115
133
4378A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other[MULTI-INFARKTIDEMENTIA]
+∞
52.9
50
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
56.4
51.9
61
12
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
4.5
49.6
220
695
N05AH04
ATC
quetiapine; oral
7.2
46.5
122
206
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
101.8
43.4
47
5
F01.0
ICD-10 Finland
Vascular dementia of acute onset
+∞
43.2
41
*
N06DA03
ATC
rivastigmine; oral, transdermal
112.7
39.2
42
*
4378X
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other[MORBUS CERBROVASCULARIS ALIA DEFINITA]
+∞
36.8
35
*
F01.14
ICD-10 Finland
Multi-infarct dementia's other mixed symptoms of mixed type
+∞
36.8
35
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
6.3
30.7
86
155
N03AG01
ATC
valproic acid; systemic, rectal
10.9
27.8
54
54
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
39.9
27.4
34
9
G30.8
ICD-10 Finland
Other Alzheimer disease
65.1
27.2
31
5
N05AD03
ATC
melperone; systemic
9.0
25.9
56
68
B01AC07
ATC
dipyridamole; systemic
3.5
25.9
140
485
N06AB04
ATC
citalopram; systemic
3.0
23.6
163
668
N06DA04
ATC
galantamine; oral
46.9
22.5
27
6
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
46.9
22.5
27
6
R41.0
ICD-10 Finland
Disorientation, unspecified
6.8
22.1
57
91
F01.11
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly paranoidism
+∞
20.9
20
*
N05AD01
ATC
haloperidol; systemic
5.4
20.6
64
130
Z75.5
ICD-10 Finland
Holiday relief care
9.9
19.9
40
43
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.5
19.7
47
67
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.3
19.2
106
367
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
45.5
18.3
22
5
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.1
18.3
59
125
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
+∞
17.8
17
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.8
17.2
49
90
F01.12
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly hallucinations
+∞
16.7
16
*
P70
ICPC
Dementia
11.2
15.6
29
27
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
3.5
15.4
75
234
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
14.6
252
1577
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
76.8
13.6
15
*
F01.13
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly depression
+∞
12.5
12
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.5
12.5
44
103
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
132.4
12.5
13
*
R53
ICD-10 Finland
Malaise and fatigue
2.2
12.2
140
727
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
6.1
11.9
32
55
N03AF02
ATC
oxcarbazepine; oral
6.9
11.9
29
44
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
+∞
11.5
11
*
F0019, G301
ICD-10 Finland
NA
+∞
11.5
11
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.7
11.4
81
328
F01
ICD-10 Finland
Vascular dementia
44.1
10.9
13
*
F05.1
ICD-10 Finland
Delirium superimposed on dementia
21.9
10.7
15
7
F01.2
ICD-10 Finland
Subcortical vascular dementia
61.0
10.6
12
*
N05AH03
ATC
olanzapine; systemic
7.0
10.5
25
37
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
3.5
10.2
48
147
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
10.1
196
1238
P20
ICPC
Memory disturbance
2.5
10.0
82
359
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.8
10.0
22
29
Z2445
NOMESCO Finland
Psychologist
8.9
9.8
20
23
N05BA06
ATC
lorazepam; systemic, sublingual
3.3
9.8
48
152
130
Kela drug reimbursment
Malignant tumour
0.1
9.7
6
387
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
55.8
9.7
11
*
N05BA04
ATC
oxazepam; oral
2.0
9.5
137
772
A06AD11
ATC
lactulose; oral
1.9
9.1
163
998
F10.20
ICD-10 Finland
Alcohol dependence currently independent
24.4
8.9
12
5
N06AX11
ATC
mirtazapine; oral
1.9
8.9
140
817
F05.9
ICD-10 Finland
Delirium, unspecified
4.7
8.9
29
64
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
8.8
29
746
F009, G309
ICD-10 Finland
NA
+∞
8.3
8
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
8.0
107
583
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
3.1
7.8
42
143
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
4.1
7.7
29
74
AA1AD
NOMESCO Finland
CT of head and brain
1.9
7.7
132
786
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.4
7.5
63
280
G30
ICD-10 Finland
Alzheimer disease
80.9
7.4
8
*
S01.0
ICD-10 Finland
Open wound of scalp
2.6
7.3
51
205
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.8
7.2
29
79
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.7
7.1
47
184
A98
ICPC
Health maint/preventive medicine
0.6
7.0
191
2567
A10AE04
ATC
insulin glargine; parenteral
2.5
6.9
52
219
SPAT1053
SPAT
Memory test
2.0
6.8
91
494
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
6.7
38
133
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.3
6.6
60
275
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.0
6.5
37
130
N06AB10
ATC
escitalopram; oral
2.3
6.5
57
258
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
6.4
97
552
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
14.5
6.4
10
7
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
6.4
78
408
L15
ICPC
Knee symptom/complaint
0.3
6.3
12
398
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.3
6.3
29
90
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.8
6.1
36
132
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
12.7
6.1
10
8
315
Kela drug reimbursment
Clopidogrel
4.2
6.0
21
51
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
50
1058
0.43
8.02
1.7
2.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
171
2407
0.60
7.32
4.3
4.5
mmol/l
3.8
4.2
4.78
157
2126
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
181
2510
0.61
7.27
4.8
5.1
mmol/l
2.1
2.4
4.25
168
2188
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
184
2533
0.61
7.12
4.7
5.1
mmol/l
6.3
6.2
0.24
156
2190
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
174
2424
0.61
7.06
22.9
19.7
ml/min/173m2
66.3
64.9
0.35
141
2037
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
170
2374
0.61
6.92
4.2
4.5
mmol/l
1.3
1.4
2.52
156
2064
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
169
2294
0.64
5.75
3.9
4.1
mmol/l
1.2
1.2
0.15
154
1984
(3002385) Erythrocyte distribution width [Ratio]
152
2106
0.63
5.64
30.2
23.9
%
14.5
14.2
1.59
146
2038
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
186
2454
0.66
5.44
7.9
6.7
mmol/mol
46.2
42.2
2.86
166
2188
(3021589) Normoblasts [#/volume] in Blood
74
1210
0.56
5.28
11.7
10.8
e9/l
0.0
0.0
0.72
60
970
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
218
2775
0.67
5.27
10.7
10.5
u/l
28.5
24.3
0.48
201
2623
(3044889) 12 lead EKG panel
142
1954
0.65
4.95
4.8
4.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
219
2718
0.70
4.28
24.7
19.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
103
1474
0.64
4.18
4.3
5.7
ug/l
2.4
8.3
1.28
83
1270
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
25
543
0.44
4.18
4.0
2.6
%
20.5
21.2
0.11
20
474
(3013707) Erythrocyte sedimentation rate by Westergren method
154
2028
0.68
4.14
3.6
4.0
mm/h
18.5
17.1
0.35
136
1817
(1761868) Lipid panel - Serum or Plasma
32
627
0.48
4.04
4.7
3.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
32
624
0.49
3.99
3.4
2.5
umol/l
10.6
11.5
0.53
27
573
(3002256) Pathology report gross observation
15
385
0.37
3.74
1.5
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
49
818
0.56
3.69
3.0
3.3
ug/l
0.9
1.0
0.34
36
581
(3010813) Leukocytes [#/volume] in Blood
240
2887
0.73
3.68
34.8
28.6
e9/l
7.7
7.2
1.91
219
2757
(42870588) Differential panel, method unspecified - Blood
62
971
0.60
3.66
3.9
4.8
—
—
—
0
0
(3024731) MCV [Entitic volume]
240
2885
0.73
3.65
34.7
28.4
fl
91.8
92.2
0.51
223
2793
(3035941) MCH [Entitic mass]
240
2885
0.73
3.65
34.6
28.4
pg
30.3
30.4
0.41
223
2791
(3026361) Erythrocytes [#/volume] in Blood
240
2885
0.73
3.65
34.7
28.5
e12/l
4.2
4.3
0.87
218
2759
(3007461) Platelets [#/volume] in Blood
240
2884
0.73
3.64
34.9
28.5
e9/l
240.3
230.1
1.37
223
2767
(3023103) Potassium [Moles/volume] in Serum or Plasma
238
2858
0.73
3.57
30.8
24.2
mmol/l
4.0
4.0
2.04
218
2745
(3019550) Sodium [Moles/volume] in Serum or Plasma
238
2856
0.73
3.54
30.9
24.1
mmol/l
139.7
139.3
1.27
220
2743
(3000963) Hemoglobin [Mass/volume] in Blood
241
2885
0.73
3.52
34.9
28.8
g/l
126.9
128.9
1.11
225
2793
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
61
375
1.69
3.46
2.8
2.7
ug/l
4.3
6.5
1.38
51
320
(3012516) Albumin [Mass/volume] in Urine
60
926
0.61
3.33
3.0
3.1
mg/l
48.7
346.3
1.75
44
623
(3019309) Folate [Moles/volume] in Red Blood Cells
114
823
1.47
3.24
2.0
1.8
nmol/l
1009.6
1183.8
1.47
91
613
(3019069) Monocytes/100 leukocytes in Blood
94
1298
0.67
3.11
4.7
5.3
%
8.9
9.1
0.27
86
1197
(3009508) Creatinine [Moles/volume] in Urine
62
932
0.63
3.07
2.8
3.1
mmol/l
7.0
6.6
0.32
45
760
(3013115) Eosinophils [#/volume] in Blood
105
1417
0.69
3.07
4.4
4.9
e9/l
0.2
0.2
0.48
90
1222
(3006504) Eosinophils/100 leukocytes in Blood
94
1294
0.68
3.05
4.6
5.0
%
2.8
2.8
0.03
85
1187
(3002030) Lymphocytes/100 leukocytes in Blood
97
1324
0.68
3.01
4.8
5.4
%
21.0
23.8
1.69
89
1212
(3000492) Spirometry study
6
195
0.30
2.98
1.5
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
84
1170
0.67
2.89
4.7
4.8
%
22.9
22.5
0.10
46
626
(3044290) Cell count panel - Cerebral spinal fluid
9
22
4.13
2.88
1.2
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
13
5.42
2.87
1.1
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
37
618
0.57
2.80
2.4
1.6
mg/l
1.0
1.4
1.35
30
489
(3022096) Basophils/100 leukocytes in Blood
93
1258
0.69
2.73
4.4
5.0
%
0.5
0.6
0.89
85
1155
(3018010) Neutrophils/100 leukocytes in Blood
96
1289
0.70
2.70
5.2
5.2
%
63.9
60.3
1.93
88
1189
(3001604) Monocytes [#/volume] in Blood
102
1355
0.70
2.70
4.4
4.8
e9/l
0.6
0.6
0.29
88
1143
(3020682) Albumin/Creatinine [Ratio] in Urine
70
990
0.67
2.59
3.5
3.9
mg/mmol
15.0
11.7
0.30
44
648
(3001122) Ferritin [Mass/volume] in Serum or Plasma
89
1203
0.70
2.59
2.8
2.8
ug/l
141.2
165.3
0.53
77
1076
(3030467) Casts [#/volume] in Urine by Automated count
72
1010
0.67
2.56
4.6
3.8
e6/l
0.8
0.5
0.32
64
812
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
196
2336
0.76
2.50
4.3
4.4
mu/l
2.0
2.1
0.58
178
2024
(3013650) Neutrophils [#/volume] in Blood by Automated count
127
1602
0.74
2.41
6.1
7.9
e9/l
5.3
4.5
1.81
106
1383
(3006315) Basophils [#/volume] in Blood
105
1364
0.72
2.41
4.5
4.8
e9/l
0.0
0.0
0.38
89
1155
(36304419) Bacteria [Presence] in Urine
68
950
0.68
2.36
4.6
3.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
151
1848
0.76
2.31
3.3
3.5
pmol/l
14.7
15.2
1.55
129
1611
(40768797) Stomach Pathology biopsy report
17
338
0.49
2.30
1.1
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
192
2276
0.77
2.30
6.3
6.9
u/l
85.0
86.3
0.12
171
2098
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
165
0.36
2.17
5.7
2.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
75
1013
0.70
2.16
4.0
3.7
ph
7.4
7.4
—
9
200
(40758558) Short blood count panel - Blood
48
705
0.65
2.15
5.5
5.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
31
500
0.60
2.09
2.5
2.2
%
1.8
1.8
0.04
24
447
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
239
2732
0.80
2.05
26.0
19.9
mg/l
32.5
30.1
0.47
212
2327
(3022145) Colonoscopy Study observation
11
243
0.44
2.01
1.6
1.2
—
—
—
0
0
(4035726)
11
242
0.44
1.99
1.2
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
63
861
0.70
1.95
2.0
1.7
nmol/l
17.4
19.6
0.45
55
735
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
11
4.56
1.94
1.2
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
11
4.56
1.94
1.2
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
109
1359
0.76
1.87
2.8
3.5
ng/l
1921.1
2867.6
1.54
92
1200
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
200
0.44
1.86
1.2
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
230
1.60
1.85
1.6
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
61
829
0.71
1.83
2.5
2.9
umol/l
7034.7
8027.2
0.05
48
677
(40761536) Microorganisms panel - Urine sediment
14
272
0.50
1.81
8.0
4.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
21
357
0.57
1.76
1.6
2.7
umol/l
6.8
12.1
1.41
15
303
(3019198) Lymphocytes [#/volume] in Blood
113
1390
0.77
1.74
4.7
5.1
e9/l
1.5
1.7
1.66
94
1203
(46235355) HIV 1 and 2 tests - Meaningful Use set
11
228
0.47
1.72
1.9
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
15
279
0.53
1.71
1.5
1.4
—
—
—
0
0
(4094501)
0
49
0.00
1.69
0.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
197
2263
0.81
1.68
25.7
21.2
%
33.8
36.5
1.16
87
1291
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
136
1624
0.79
1.64
4.3
5.4
umol/l
11.1
13.7
2.22
123
1529
(3013512) EKG study
76
977
0.75
1.61
5.4
4.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
59
784
0.73
1.56
6.4
4.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
91
1132
0.77
1.53
4.2
3.8
e6/l
28.8
148.1
1.46
80
925
(21494434) Karyotype in Bone marrow
0
44
0.00
1.51
0.0
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
120
985
1.27
1.51
2.5
2.0
u/l
260.3
253.0
0.04
109
909
(3027273) Bicarbonate [Moles/volume] in Venous blood
32
210
1.55
1.50
4.7
3.1
mmol/l
24.7
24.9
0.11
32
202
(3043409) Potassium [Moles/volume] in Arterial blood
20
116
1.75
1.49
3.2
3.3
mmol/l
4.0
4.1
0.06
20
102
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
80
1.89
1.45
2.7
2.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
134
1.66
1.40
2.0
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
37
522
0.69
1.40
4.6
4.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
25
382
0.64
1.40
1.2
1.3
g/l
2.2
2.7
1.16
18
220
(3018095) Leukocytes [#/volume] in Urine
103
1247
0.79
1.39
4.5
4.3
e6/l
271.9
174.0
0.25
82
978
(3026008) Bacteria identified in Urine by Culture
138
1165
1.23
1.36
3.8
3.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
126
1487
0.81
1.35
6.8
5.4
mmol/l
1.2
1.2
1.50
107
1295
(3039443) Prostate specific Ag panel - Serum or Plasma
0
37
0.00
1.34
0.0
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
38
0.00
1.34
0.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
21
330
0.62
1.33
4.3
4.8
%
33.6
33.5
0.01
16
205
(4010399)
9
172
0.52
1.31
1.8
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
45
600
0.73
1.24
1.3
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
67
843
0.77
1.24
3.5
3.1
e6/l
4.6
4.4
0.05
58
749
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
187
0.53
1.21
1.3
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
148
1.57
1.21
1.9
2.0
u/ml
0.3
0.4
0.58
16
83
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
126
0.47
1.18
1.2
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
19
295
0.63
1.17
6.4
3.8
mmol/l
1.2
1.2
0.40
14
251
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
34
0.00
1.16
0.0
1.6
—
2.5
—
0
27
(3023368) Bacteria identified in Blood by Culture
132
1136
1.20
1.08
4.7
4.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
110
1282
0.83
1.04
4.2
3.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.2
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
47
362
1.32
1.00
15.5
9.6
—
—
—
0
0
(4024509)
5
23
2.18
0.98
1.2
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(4146454)
0
29
0.00
0.98
0.0
3.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
30
0.00
0.97
0.0
3.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
198
0.60
0.97
2.3
2.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
196
0.60
0.94
1.8
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
28
2.15
0.91
6.8
25.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
117
1338
0.84
0.90
3.9
4.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
26
185
1.42
0.90
3.5
2.4
%
0.8
0.7
0.67
26
180
(3026782) Osmolality of Urine
68
817
0.81
0.88
4.4
3.3
mosm/kgh2o
628.2
547.2
2.07
51
701
(3025941) Bacteria identified in Stool by Culture
8
140
0.57
0.83
1.5
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
24
0.00
0.79
0.0
3.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
25
0.00
0.79
0.0
1.0
—
5.1
—
0
5
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
3.2
—
10.2
—
0
25
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
147
1633
0.87
0.78
7.1
6.0
mmol/l
1.2
1.2
0.50
120
1316
(3017569) Oxygen content in Arterial blood
0
26
0.00
0.78
0.0
4.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
125
0.55
0.78
1.9
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
230
0.69
0.74
1.6
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
38
1.85
0.73
6.3
4.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
40
497
0.79
0.72
1.7
1.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
153
1.38
0.67
2.2
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
47
385
1.24
0.67
3.8
3.6
mmol/l
2.2
2.0
0.09
39
295
(3007853) Bacteria identified in Skin by Aerobe culture
46
376
1.24
0.66
1.6
1.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
28
1.79
0.66
5.4
3.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
190
2053
0.89
0.65
5.6
4.8
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
5
29
1.73
0.64
1.8
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
39
477
0.80
0.63
6.2
4.7
mmol/l
1.1
1.1
0.02
33
440
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
176
0.67
0.63
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
28
217
1.30
0.62
3.9
3.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
97
1090
0.87
0.62
2.3
2.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
22
0.00
0.59
0.0
2.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
54
456
1.20
0.59
5.8
5.7
mmol/l
1.2
1.3
0.04
35
327
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
23
0.00
0.58
0.0
1.3
—
22.6
—
0
17
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
23
0.00
0.58
0.0
1.2
—
334242.1
—
0
17
(3003338) MCHC [Mass/volume]
193
2068
0.90
0.57
32.1
26.7
g/l
328.7
330.0
0.83
182
2025
(40761535) Cells panel - Urine sediment
35
284
1.24
0.56
5.4
4.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
73
830
0.86
0.55
2.5
2.7
u/l
57.0
37.9
0.44
66
799
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
49
576
0.84
0.55
3.3
3.3
e6/l
1.9
1.4
0.46
31
357
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
8
122
0.65
0.55
4.3
3.2
—
2.7
—
0
13
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
53
453
1.18
0.52
5.8
5.7
kpa
4.9
5.1
0.73
46
417
(1761482) Bacteria [#/volume] in Urine by Culture
20
152
1.32
0.52
6.1
4.9
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
53
454
1.18
0.51
5.8
5.7
kpa
11.0
11.1
0.04
46
420
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
34
279
1.23
0.50
2.0
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
200
0.74
0.49
2.9
3.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
28
343
0.81
0.48
2.5
2.4
g/l
63.7
65.2
0.50
22
307
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
128
1.34
0.47
1.3
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
47
1.49
0.47
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
556
0.85
0.47
3.3
3.5
e6/l
1.5
2.0
0.43
30
340
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
116
0.68
0.46
1.6
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
71
629
1.14
0.46
6.7
5.2
kg/l
1.0
1.0
0.50
11
103
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
5
82
0.61
0.46
4.2
2.1
mg/l
1.9
2.2
—
5
69
(3037522) Nuclear Ab [Titer] in Serum
18
231
0.77
0.46
1.2
1.3
titre
228.6
330.4
—
7
54
(3035350) Ketones [Presence] in Urine by Test strip
130
1402
0.91
0.44
5.9
4.5
estimate
0.0
0.0
0.00
14
293
(3029937) Albumin [Presence] in Urine by Test strip
72
801
0.88
0.42
7.2
4.8
estimate
0.0
0.0
—
9
265
(3004588) Protein electrophoresis panel - Serum or Plasma
23
282
0.81
0.41
2.3
2.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
131
1408
0.91
0.41
6.0
4.7
estimate
0.0
0.0
0.00
12
280
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
33
1.52
0.41
1.4
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.1
—
0
10
(4306422)
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
17
0.00
0.40
0.0
1.2
—
12.4
—
0
6
(40768441) Liver Pathology biopsy report
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
177
1875
0.92
0.40
6.1
4.7
mmol/l
7.7
7.0
1.80
164
1760
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
130
1395
0.91
0.40
8.0
6.3
estimate
0.0
0.0
0.00
14
285
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
90
983
0.90
0.39
2.3
2.3
mg/l
2.8
3.3
1.35
72
839
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
132
1414
0.91
0.39
2.6
2.2
pmol/l
85.0
89.1
0.51
85
773
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
32
374
0.85
0.37
5.3
4.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
37
1.35
0.37
1.6
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
217
1.20
0.35
5.4
4.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
74
671
1.11
0.35
39.8
32.6
inr
1.7
1.5
0.48
15
89
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
46
1.31
0.33
1.0
1.3
—
—
—
0
0
(3019225) pH of Specimen
25
293
0.85
0.31
4.8
3.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
55
1.27
0.30
2.0
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
67
728
0.91
0.28
2.1
2.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
15
183
0.81
0.28
4.6
4.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
134
1412
0.93
0.28
3.8
2.8
u/l
49.9
58.9
1.04
119
1271
(3020891) Body temperature
18
149
1.21
0.27
6.8
3.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
104
1106
0.93
0.27
7.1
5.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
113
1.24
0.26
4.9
4.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
81
0.74
0.24
1.0
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
659
1.09
0.23
2.6
3.2
mmol/l
2.5
2.5
0.58
55
557
(3019060) Gas panel - Arterial blood
32
285
1.13
0.22
3.9
3.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
95
0.73
0.22
4.4
2.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.2
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.9
—
56.7
—
0
10
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
4.9
—
35.6
—
0
5
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.8
—
120.9
—
0
10
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.1
—
289.6
—
0
5
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
11
0.00
0.21
0.0
2.2
—
44.2
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
83
780
1.07
0.21
1.7
1.8
pmol/l
447.9
9076860.7
0.50
64
628
(3014576) Chloride [Moles/volume] in Serum or Plasma
49
450
1.09
0.21
7.3
6.5
mmol/l
105.8
104.1
1.65
49
435
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
89
1.24
0.20
1.5
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
48
1.25
0.20
1.5
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
95
1000
0.94
0.20
2.2
2.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
12
99
1.21
0.19
2.7
4.3
mg/l
13.9
34.6
—
7
68
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
51
1.18
0.19
2.2
1.6
mg/l
14.6
25.2
—
6
42
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
102
1069
0.94
0.19
2.0
2.1
nmol/l
70.2
79.2
2.97
79
918
(36660697) Celiac disease serology panel - Serum
11
131
0.84
0.17
1.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
110
1.18
0.17
1.7
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
110
1.18
0.17
1.7
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
67
0.74
0.17
1.8
2.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
70
0.71
0.16
3.0
2.2
g/l
3.3
3.6
—
5
65
(3024561) Albumin [Mass/volume] in Serum or Plasma
137
1417
0.96
0.16
4.6
4.4
g/l
34.3
33.5
0.84
125
1297
(3000991) Gas panel - Venous blood
34
313
1.09
0.15
7.1
7.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
88
0.79
0.14
3.1
3.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
90
937
0.95
0.14
2.4
2.3
u/l
47.0
56.0
3.19
84
865
(3011397) Hemoglobin [Presence] in Urine by Test strip
67
638
1.05
0.13
5.8
4.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
72
751
0.95
0.12
5.5
4.1
ng/l
117.6
281.0
1.12
64
675
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
67
640
1.05
0.11
2.2
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.2
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
44
1.14
0.10
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
43
451
0.95
0.09
1.9
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
141
1439
0.97
0.09
5.2
4.7
ng/l
52.0
58.8
0.22
113
1143
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
55
1.09
0.09
1.0
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
60
0.83
0.08
1.4
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
60
0.83
0.08
1.2
1.1
u/l
9.1
56.1
—
5
55
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
62
0.80
0.08
1.2
1.2
—
0.2
—
0
6
(3015377) Calcium [Moles/volume] in Serum or Plasma
107
1042
1.03
0.08
2.5
3.1
mmol/l
2.3
2.3
0.52
88
886
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
175
1.09
0.08
10.9
7.8
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
19
205
0.92
0.08
9.1
7.6
mmol/l
23.8
24.7
0.55
13
179
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
65
0.77
0.08
1.2
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
65
0.77
0.08
1.6
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
67
1.04
0.08
1.4
1.4
—
—
—
0
0
(4034850)
7
83
0.84
0.07
4.4
13.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
88
1.02
0.07
1.3
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
95
0.84
0.06
1.9
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
12
130
0.92
0.05
5.4
4.4
mmol/l
25.6
24.6
0.64
12
125
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
24
251
0.95
0.04
2.3
3.8
ng/l
113.2
104.0
0.14
16
218
(3012095) Magnesium [Moles/volume] in Serum or Plasma
53
516
1.03
0.04
2.3
2.8
mmol/l
0.8
0.8
0.11
46
472
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
44
450
0.97
0.03
1.9
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
232
1.03
0.02
2.6
3.3
ml/min/173m2
45.3
54.8
—
7
117
(3045414) Leukocytes [Presence] in Urine
11
103
1.07
0.01
1.6
2.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
18
173
1.04
0.01
2.1
1.7
ug/l
0.6
2.8
0.70
12
144
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
141
0.99
0.00
2.0
2.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
154
1540
1.00
0.00
14.3
13.6
inr
1.4
1.5
0.12
28
419
(3009445) Proteinase 3 Ab [Units/volume] in Serum
12
118
1.02
0.00
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
77
0.91
0.00
1.7
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
77
0.91
0.00
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
77
0.91
0.00
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
59
1.02
0.00
1.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.3
—
6.5
—
0
8
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
12.5
—
13.9
—
0
6
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
0.7
—
0
8
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
89
0.90
0.00
1.1
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
1031.4
—
0
8
(3042631) Mycobacterium sp identified in Specimen
5
55
0.91
0.00
3.2
3.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
76
0.92
0.00
1.1
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
122.6
—
0
5
(3012441) Differential panel - Pleural fluid
7
72
0.97
0.00
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
12.8
—
7.0
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
85
0.94
0.00
1.3
1.4
—
40.2
—
0
6
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
8.4
—
0
5
(44813793)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
2.0
—
0
6
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
40.8
—
0
9
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
59
1.02
0.00
1.7
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
102.4
—
0
9
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint VD_MI and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| VD_MI | 2.991 [2.64, 3.39] | < 0.001 |
| Birth year | 1.0 [0.99, 1.01] | 0.916 |
During the follow-up period (1.1.1998 — 31.12.2019), 3138 out of 3584 females with VD_MI died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| VD_MI | 3.558 [2.97, 4.26] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 2806 out of 3330 males with VD_MI died.
Mortality risk
Mortality risk for people of age
years, who have VD_MI.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.241% | 0.492% |
| 5 | 1.79% | 3.705% |
| 10 | 4.924% | 9.421% |
| 15 | 9.633% | 17.903% |
| 20 | 16.907% | 28.507% |
Relationships between endpoints
↥Index endpoint: VD_MI – Vascular dementia (multiple infarctions)
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data